136 related articles for article (PubMed ID: 37729335)
21. Clostridium difficile colitis after kidney and kidney-pancreas transplantation.
West M; Pirenne J; Chavers B; Gillingham K; Sutherland DE; Dunn DL; Matas AJ
Clin Transplant; 1999 Aug; 13(4):318-23. PubMed ID: 10485373
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cytomegalovirus "Blips" in high-risk kidney/kidney-pancreas transplant recipients.
Payne AT; Lindner BK; Gilbert AJ; Kumar RN; Thomas BS; Timpone JG
Transpl Infect Dis; 2022 Apr; 24(2):e13789. PubMed ID: 35014122
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation.
Herrero-Martínez JM; Lumbreras C; Manrique A; San-Juan R; García-Reyne A; López-Medrano F; Lizasoain M; de Dios B; Andrés A; Jiménez C; Gutiérrez E; Moreno E; Aguado JM
Clin Microbiol Infect; 2013 Dec; 19(12):1132-9. PubMed ID: 23480521
[TBL] [Abstract][Full Text] [Related]
24. Pancreas after kidney transplants.
Humar A; Ramcharan T; Kandaswamy R; Matas A; Gruessner RW; Gruessner AC; Sutherland DE
Am J Surg; 2001 Aug; 182(2):155-61. PubMed ID: 11574088
[TBL] [Abstract][Full Text] [Related]
25. Severe Strongyloides stercoralis infection in kidney transplant recipients: A multicenter case-control study.
Miglioli-Galvão L; Pestana JOM; Santoro-Lopes G; Torres Gonçalves R; Requião Moura LR; Pacheco Silva Á; Camera Pierrotti L; David Neto E; Santana Girão E; Costa de Oliveira CM; Saad Abboud C; Dias França JÍ; Devite Bittante C; Corrêa L; Aranha Camargo LF
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007998. PubMed ID: 32004346
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.
Radisic M; Lattes R; Chapman JF; del Carmen Rial M; Guardia O; Seu F; Gutierrez P; Goldberg J; Casadei DH
Transpl Infect Dis; 2003 Jun; 5(2):84-93. PubMed ID: 12974789
[TBL] [Abstract][Full Text] [Related]
27. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
Aziz F; Jorgenson MR; Parajuli S; Zhong W; Hidalgo LG; Djamali A; Mandelbrot D; Odorico J; Sollinger H; Astor BC; Mohamed MA
Transpl Infect Dis; 2020 Jun; 22(3):e13272. PubMed ID: 32112710
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.
Gras J; De Castro N; Montlahuc C; Champion L; Scemla A; Matignon M; Lachâtre M; Raskine L; Grall N; Peraldi MN; Molina JM
Transpl Infect Dis; 2018 Oct; 20(5):e12943. PubMed ID: 29890021
[TBL] [Abstract][Full Text] [Related]
30. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.
Peleg AY; Husain S; Qureshi ZA; Silveira FP; Sarumi M; Shutt KA; Kwak EJ; Paterson DL
Clin Infect Dis; 2007 May; 44(10):1307-14. PubMed ID: 17443467
[TBL] [Abstract][Full Text] [Related]
31. Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients.
Stehman-Breen CO; Psaty BM; Emerson S; Gretch D; Bronner M; Marsh C; Davis CL
Transplantation; 1997 Jul; 64(2):281-6. PubMed ID: 9256188
[TBL] [Abstract][Full Text] [Related]
32. Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber PW; Laager M; Boggian K; Neofytos D; van Delden C; Egli A; Dickenmann M; Hirzel C; Manuel O; Koller M; Rossi S; Schmied B; Gürke L; Matter M; Berney T; de Rougemont O; Kuster SP; Stampf S; Mueller NJ;
J Hosp Infect; 2022 Oct; 128():47-53. PubMed ID: 35840001
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kizilisik AT; Alloway RR; Gaber LW; Gaber AO
Clin Transplant; 2000 Dec; 14(6):572-9. PubMed ID: 11127311
[TBL] [Abstract][Full Text] [Related]
34. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
36. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
37. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of varicella zoster virus infection morbidity and mortality in pancreas and kidney-pancreas transplant recipients.
Netchiporouk E; Tchervenkov J; Paraskevas S; Sasseville D; Billick R
Transplant Proc; 2013 Mar; 45(2):701-4. PubMed ID: 23453544
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of early corticosteroid elimination after pancreas transplantation.
Hanaway MJ; Roy-Chaudhury P; Buell JF; Thomas M; Munda R; Alloway RR; Ellison V; Rudich SM; Fisher L; Woodle ES
Transplant Proc; 2005 Mar; 37(2):1287-8. PubMed ID: 15848698
[TBL] [Abstract][Full Text] [Related]
40. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
